Folate Receptor-Targeted Dendrimer-Methotrexate Conjugate for Inflammatory Arthritis
Folate Receptor-Targeted Dendrimer-Methotrexate Conjugate for Inflammatory Arthritis
复制标题
叶酸受体靶向树枝状大分子-甲氨蝶呤缀合物治疗炎症性关节炎
DOI:
10.1166/jbn.2015.2077
复制
发表时间:
2015-08-01
影响因子:
2.9
通讯作者:
Baker, James R., Jr.
中科院分区:
文献类型:
--
作者:
Qi, Rong;Majoros, Istvan;Baker, James R., Jr.
Generation 5 (G5) poly(amidoamide) (PAMAM) dendrimers are synthetic polymers that have been broadly applied as drug delivery carriers. Methotrexate (MTX), an anti-folate metabolite, has been successfully used as an anti-inflammatory drug to treat rheumatoid arthritis (RA) in the clinic. In this study, we examine the therapeutic efficacy of G5 PAMAM dendrimer methotrexate conjugates (G5-MTX) that also have folic acid (FA) conjugated to the G5-MTX (G5-FA-MTX) to target inflammation-activated folate receptors overexpressing macrophages. These cells are thought to play an important role in the development of RA. With G5 serving as a control, the in vitro binding affinities of G5-FA-MTX and G5-MTX to activated macrophages were assessed in RAW264.7, NR8383 and primary rat peritoneal macrophages. The results indicated that the binding of either conjugate to macrophages was concentration- and temperature-dependent and could be blocked by the presence of 6.25 mM free FA (p < 0.005). The preventive effects of G5-MTX and G5-FA-MTX conjugates on the development of arthritis were explored on an adjuvant-induced inflammatory arthritis model and had similar preventive effects in inflammatory arthritis at a MIX equivalent dose of 4.95 mu mol/kg. These studies indicated that when multiples of MTX are conjugated on dendritic polymers, they specifically bind to folate receptor overexpressing macrophages and have comparable anti-inflammatory effects to folate targeted MTX conjugated polymers.